Regeneron Pharmaceuticals Inc (REGN)

Debt-to-assets ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-term debt	US$ in thousands	1,984,400	1,982,900	1,981,400	1,980,000	1,978,500
Total assets	US$ in thousands	37,759,400	33,080,200	29,214,500	25,434,800	17,163,300
Debt-to-assets ratio		0.05	0.06	0.07	0.08	0.12

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,984,400K ÷ $37,759,400K
= 0.05

The debt-to-assets ratio of Regeneron Pharmaceuticals Inc has shown a decreasing trend over the years, indicating an improving financial position in terms of leverage. As of December 31, 2020, the ratio was 0.12, which has steadily decreased to 0.05 by December 31, 2024. This implies that the company's level of debt relative to its total assets has been declining. A lower debt-to-assets ratio signifies that the company relies less on debt financing and has a higher proportion of equity funding its assets. This could indicate a reduced financial risk and improved solvency for Regeneron Pharmaceuticals Inc.